355 related articles for article (PubMed ID: 24117861)
1. IgE-based immunotherapy of cancer: challenges and chances.
Singer J; Jensen-Jarolim E
Allergy; 2014 Feb; 69(2):137-49. PubMed ID: 24117861
[TBL] [Abstract][Full Text] [Related]
2. An immunologically relevant rodent model demonstrates safety of therapy using a tumour-specific IgE.
Josephs DH; Nakamura M; Bax HJ; Dodev TS; Muirhead G; Saul L; Karagiannis P; Ilieva KM; Crescioli S; Gazinska P; Woodman N; Lombardelli C; Kareemaghay S; Selkirk C; Lentfer H; Barton C; Canevari S; Figini M; Downes N; Dombrowicz D; Corrigan CJ; Nestle FO; Jones PS; Gould HJ; Blower PJ; Tsoka S; Spicer JF; Karagiannis SN
Allergy; 2018 Dec; 73(12):2328-2341. PubMed ID: 29654623
[TBL] [Abstract][Full Text] [Related]
3. IgE immunotherapy against cancer.
Leoh LS; Daniels-Wells TR; Penichet ML
Curr Top Microbiol Immunol; 2015; 388():109-49. PubMed ID: 25553797
[TBL] [Abstract][Full Text] [Related]
4. AllergoOncology: the role of IgE-mediated allergy in cancer.
Jensen-Jarolim E; Achatz G; Turner MC; Karagiannis S; Legrand F; Capron M; Penichet ML; Rodríguez JA; Siccardi AG; Vangelista L; Riemer AB; Gould H
Allergy; 2008 Oct; 63(10):1255-66. PubMed ID: 18671772
[TBL] [Abstract][Full Text] [Related]
5. IgE immunotherapy: a novel concept with promise for the treatment of cancer.
Josephs DH; Spicer JF; Karagiannis P; Gould HJ; Karagiannis SN
MAbs; 2014; 6(1):54-72. PubMed ID: 24423620
[TBL] [Abstract][Full Text] [Related]
6. AllergoOncology - the impact of allergy in oncology: EAACI position paper.
Jensen-Jarolim E; Bax HJ; Bianchini R; Capron M; Corrigan C; Castells M; Dombrowicz D; Daniels-Wells TR; Fazekas J; Fiebiger E; Gatault S; Gould HJ; Janda J; Josephs DH; Karagiannis P; Levi-Schaffer F; Meshcheryakova A; Mechtcheriakova D; Mekori Y; Mungenast F; Nigro EA; Penichet ML; Redegeld F; Saul L; Singer J; Spicer JF; Siccardi AG; Spillner E; Turner MC; Untersmayr E; Vangelista L; Karagiannis SN
Allergy; 2017 Jun; 72(6):866-887. PubMed ID: 28032353
[TBL] [Abstract][Full Text] [Related]
7. Recombinant IgE antibodies for passive immunotherapy of solid tumours: from concept towards clinical application.
Karagiannis SN; Josephs DH; Karagiannis P; Gilbert AE; Saul L; Rudman SM; Dodev T; Koers A; Blower PJ; Corrigan C; Beavil AJ; Spicer JF; Nestle FO; Gould HJ
Cancer Immunol Immunother; 2012 Sep; 61(9):1547-64. PubMed ID: 22139135
[TBL] [Abstract][Full Text] [Related]
8. IgE-antibody-dependent immunotherapy of solid tumors: cytotoxic and phagocytic mechanisms of eradication of ovarian cancer cells.
Karagiannis SN; Bracher MG; Hunt J; McCloskey N; Beavil RL; Beavil AJ; Fear DJ; Thompson RG; East N; Burke F; Moore RJ; Dombrowicz DD; Balkwill FR; Gould HJ
J Immunol; 2007 Sep; 179(5):2832-43. PubMed ID: 17709497
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of anti-antiidiotypic IgE antibodies obtained from an IgE monoclonal antibody specific for a 26-kilodalton Schistosoma mansoni antigen.
Velge-Roussel F; Verwaerde C; Grzych JM; Auriault A; Capron A
J Immunol; 1989 Apr; 142(7):2527-32. PubMed ID: 2494262
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy approach to allergic disease.
Fick RB; Fox JA; Jardieu PM
Immunopharmacology; 2000 Jul; 48(3):307-10. PubMed ID: 10960673
[TBL] [Abstract][Full Text] [Related]
11. Harnessing Therapeutic IgE Antibodies to Re-educate Macrophages against Cancer.
Pellizzari G; Bax HJ; Josephs DH; Gotovina J; Jensen-Jarolim E; Spicer JF; Karagiannis SN
Trends Mol Med; 2020 Jun; 26(6):615-626. PubMed ID: 32470387
[TBL] [Abstract][Full Text] [Related]
12. Precision medicine in clinical oncology: the journey from IgG antibody to IgE.
Fazekas-Singer J; Singer J; Jensen-Jarolim E
Curr Opin Allergy Clin Immunol; 2020 Jun; 20(3):282-289. PubMed ID: 32349107
[TBL] [Abstract][Full Text] [Related]
13. Engineering and stable production of recombinant IgE for cancer immunotherapy and AllergoOncology.
Crescioli S; Chiaruttini G; Mele S; Ilieva KM; Pellizzari G; Spencer DIR; Gardner RA; Lacy KE; Spicer JF; Tutt ANJ; Wagner GK; Karagiannis SN
J Allergy Clin Immunol; 2018 Apr; 141(4):1519-1523.e9. PubMed ID: 29360527
[No Abstract] [Full Text] [Related]
14.
Man F; Koers A; Karagiannis P; Josephs DH; Bax HJ; Gilbert AE; Dodev TS; Mele S; Chiarruttini G; Crescioli S; Chauhan J; Blower JE; Cooper MS; Spicer J; Karagiannis SN; Blower PJ
Oncoimmunology; 2021; 10(1):1966970. PubMed ID: 34513315
[TBL] [Abstract][Full Text] [Related]
15. IgE Antibodies against Cancer: Efficacy and Safety.
Chauhan J; McCraw AJ; Nakamura M; Osborn G; Sow HS; Cox VF; Stavraka C; Josephs DH; Spicer JF; Karagiannis SN; Bax HJ
Antibodies (Basel); 2020 Oct; 9(4):. PubMed ID: 33081206
[TBL] [Abstract][Full Text] [Related]
16. AllergoOncology: High innate IgE levels are decisive for the survival of cancer-bearing mice.
Singer J; Achatz-Straussberger G; Bentley-Lukschal A; Fazekas-Singer J; Achatz G; Karagiannis SN; Jensen-Jarolim E
World Allergy Organ J; 2019; 12(7):100044. PubMed ID: 31388397
[TBL] [Abstract][Full Text] [Related]
17. A novel IgE antibody targeting the prostate-specific antigen as a potential prostate cancer therapy.
Daniels-Wells TR; Helguera G; Leuchter RK; Quintero R; Kozman M; Rodríguez JA; Ortiz-Sánchez E; Martínez-Maza O; Schultes BC; Nicodemus CF; Penichet ML
BMC Cancer; 2013 Apr; 13():195. PubMed ID: 23594731
[TBL] [Abstract][Full Text] [Related]
18. IgE-based Immunotherapy of Cancer -A Comparative Oncology Approach.
Singer J; Jensen-Jarolim E
J Carcinog Mutagen; 2014 May; 5(3):1000176. PubMed ID: 25264496
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies specific for human IgE-producing B cells: a potential therapeutic for IgE-mediated allergic diseases.
Chang TW; Davis FM; Sun NC; Sun CR; MacGlashan DW; Hamilton RG
Biotechnology (N Y); 1990 Feb; 8(2):122-6. PubMed ID: 1369991
[TBL] [Abstract][Full Text] [Related]
20. Animal models for IgE-meditated cancer immunotherapy.
Daniels TR; Martínez-Maza O; Penichet ML
Cancer Immunol Immunother; 2012 Sep; 61(9):1535-46. PubMed ID: 22193986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
